Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Placebo-controlled Study to Evaluate the Beneficial Effects of Supplementation With CRONILIEF™ (Palmitoylethanolamide Phospholipids), in Addition to Standard Therapy, in Diabetic Subjects With Neuropathic Pain.

NCT07377409 is registered in ClinicalTrials.gov with Azienda di Servizi alla Persona di Pavia as lead sponsor.

NCT NCT07377409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07377409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Placebo-controlled Study to Evaluate the Beneficial Effects of Supplementation With CRONILIEF™ (Palmitoylethanolamide Phospholipids), in Addition to Standard Therapy, in Diabetic Subjects With Neuropathic Pain.
Lead sponsor
Azienda di Servizi alla Persona di Pavia
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 15, 2026
Completion date
January 15, 2027
Enrollment
70 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathies, painful, neuropathic pain management, palmitoylethanolamide